Navigation Links
Depakote in Medical News

Abbott Reports Strong Second Quarter Results; Confirms Double-Digit Earnings Growth Outlook for 2009

...eneric competition for Depakote. This resulted in a $306 million decline in depakote sales in the second quarter, reducing reported U.S. pharmaceutical sales gr...t of foreign exchange. This occurred despite the negative impact from lower depakote sales. Q4) How did R&D and SG&A investment compare to t...

FDA Approves Lamictal(R)XR(TM); An Extended-Release Once-Daily, New Generation Treatment for Epilepsy

...lity of human life by enabling people to do more, feel better and live longer. For further information please visit www.gsk.com *Depakene and depakote are registered trademarks of Abbott Laboratories GlaxoSmithKline cautionary statement regarding forward-looking statements Under the safe har...

FDA Approves Lamictal(R) ODT(TM) Orally Disintegrating Tablets

...breakthrough bleeding, while taking Lamictal and birth control pills. These are not all the possible side effects of Lamictal. *Depakene and depakote are registered trademarks of Abbott Laboratories For full prescribing information including Boxed Warning, please visit www.lamictal.com and ...

Abbott Reports 16 Percent Earnings Growth in First Quarter; Confirms Double-Digit Earnings Growth Outlook for 2009

...hange rates, increased 0.9 percent. The decline in depakote sales lowered worldwide pharmaceutical sales growt... 9.7 (17.4) (7.7) depakote $19 (0.7) (18.7) ...of generic competition for both forms of Depakote; depakote DR and...

Abbott Reports Double-Digit Sales and Earnings Growth in Fourth Quarter; Confirms Strong Outlook for 2009 Earnings

...letra $152 (0.7) $226 3.5 b $378 1.8 depakote $244 (43.8) $24 (9.1) $268 (41.8) Niasp...letra $513 (4.7) $961 22.1 b $1,474 11.2 depakote $1,262 (14.8) $102 7.4 $1,364 (13.4) TriCo...

Despite Availability of Generic Equivalents, Two-Thirds of Neurologists Will Continue to Prescribe Branded Anti-Epileptic Drugs to Epilepsy Patients

...tion, most significantly in epilepsy, for Abbott's depakote ER. Our survey showed that 79 percent of neurologi... patients from the brand to the generic version of depakote ER. Physicians' concerns are a result of this agen...rsions of UCB's Keppra, Ortho-McNeil's Topamax and depakote ER have become available, more than half of 20 sur...

FDA Adds Suicide Warning to Epilepsy Drugs

...FDA-mandated labeling are: carbamazepine (marketed as Carbatrol, Equetro, Tegretol, Tegretol XR); clorazepate (Tranxene); divalproex sodium (Depakote, depakote ER, Depakene); ethosuximide (Zarontin); ethotoin (Peganone); felbamate (Felbatol); gabapentin (Neurontin); lamotrigine (Lamictal); lacosamide (Vimpat)...

December 2008 Mayo Clinic Health Letter Highlights: Colorectal Screenings, Lighting Tips for Low Vision and Generic Medications

...able as generic since 2006: Altace (ramipril) for blood pressure and heart failure Ambien (zolpidem), a sleep aid depakote (divalproex) for seizures, migraines and bipolar disorder Fosamax (alendronate) for osteoporosis Requip (ropinirole) for restless leg...

Jefferson researcher awarded NIH grant

...for a certain period of time following treatment. Trial participants will be randomly broken into four groups and prescribed either Dilantin, Keppra, depakote or no medication to see if there are any potential short- or long-term effects on cardiovascular risk factors. ...

Lupin Receives USFDA Approval for Divalproex Sodium Delayed-Release Tablets

...ibed alone or with other epilepsy medications. The delayed-release tablets are also used to control the manic episodes that occur in bipolar disorder. depakote had annual sales of approximately $803 million for the twelve months ended March 2008, based on IMS Health sales data. About Lupin Headquartered i...
Other Tags
(Date:7/12/2014)... 12, 2014 Casinos in ... rising competition from international and online casinos. Revenue is ... the five years through 2014-15. Greater per capita gambling ... gaming services. Rises in discretionary income levels have also ... on non-essential items such as casino gambling services. Revenue ...
(Date:7/12/2014)... "The second toes cross over the big ... wear shoes," said an inventor from East Hartford, Conn. This ... from happening. , He then created a prototype of the ... second and big toes from overlapping. This avoids discomfort and ... and easy to use, it's ideal for people with foot ...
(Date:7/12/2014)... 12, 2014 Using and carrying around ... two inventors from Ashland, Va., decided that there needed ... inspired us to conceive of our design," he said. ... KIDNEY KOVER, which provides an inconspicuous way to use ... as well as promotes comfort and peace of mind. ...
(Date:7/12/2014)... Beverly Hills, CA (PRWEB) July 12, 2014 ... reason why are bodies can readily absorb the nutrients in ... into tiny particles that are small enough to be absorbed ... the DZ10 team, a lack of enzymes in regular food ... DZ10 is a product that was started by Michelle DelPresto, ...
(Date:7/12/2014)... Doylestown Hospital recently conducted an interview with Dr. ... Paddock tackles topics including main men's health concerns, ... than men, and testosterone replacement therapy, among others. In ... on Doylestown Hospital’s website, Dr. Brad Paddock says, “A ... you notice pain, bulging, or asymmetry in your lower ...
Breaking Medicine News(10 mins):Health News:Casinos in Australia Industry Market Research Report Now Updated by IBISWorld 2Health News:Casinos in Australia Industry Market Research Report Now Updated by IBISWorld 3Health News:Casinos in Australia Industry Market Research Report Now Updated by IBISWorld 4Health News:New Super Digestive Enzyme, DZ10, Supercharges The Digestion Process 2Health News:Ivyland Medical Center’s Dr. Brad Paddock Offers Tips for Men’s Health 2
(Date:7/10/2014)... 27, 2014  Pomerantz LLP has filed a ... or the "Company")(NYSE-MKT: PVCT) and certain of its ... District Court, Middle District of Tennessee ... a class consisting of all persons or entities ... December 17, 2013 and May 22, 2014, both ...
(Date:7/10/2014)... , July 2, 2014 NXT-ID, Inc., (OTCQB: NXTD) a biometric ... CEO Mr. Gino Pereira was interviewed on July ... Tampa Florida . Mr. Pereira discusses the ... Cedric Harris and how the Wocket™ aims to replace ... Cedric Harris tells Gino he has ...
(Date:7/10/2014)... , July 8, 2014 ... a new design win (DW). An Asian OEM has selected ... mass production start in August 2014.   FPC ... OEM, which has a planned date for start of mass ... ramp order of SEK 5M, for delivery in the first ...
Breaking Biology News(10 mins):SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action against Provectus Biopharmaceuticals, Inc. and Certain Officers - PVCT 2SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action against Provectus Biopharmaceuticals, Inc. and Certain Officers - PVCT 3Security and Your Money: Tampa Bay Radio Host Cedric Harris Talks to NXT-ID CEO Mr. Gino Pereira about the Wocket Smart Wallet 2Security and Your Money: Tampa Bay Radio Host Cedric Harris Talks to NXT-ID CEO Mr. Gino Pereira about the Wocket Smart Wallet 3Security and Your Money: Tampa Bay Radio Host Cedric Harris Talks to NXT-ID CEO Mr. Gino Pereira about the Wocket Smart Wallet 4FPC Wins DW and Initial Ramp Order for FPC1021 Touch Sensor for Flagship Smartphone from Asian OEM 2
Other Contents